Skip to main content

The latest Biotech H1 2017 Barometer is available

Date : 06/15/2017 - 19:20

For your information, the latest Biotech Barometer is available here

Here are the key takeaways, observed on the 47 biotech issuers of the panel:

- A total market capitalization of €13.9Bn, a valuation close to the historical highs observed for the sector.
- Valuation levels up sharply, with a general improvement in market trends in the sector.
Interest in the sector confirmed to investors (observed in the last quarter of 2016), with rising levels of liquidity and capital invested:
> Trading volumes on average per day up +41%
> A stable number of investors in the capital of the 47 listed biotechs (335 institutional)
> A positive estimate of the investment flows to companies over 3 months, with approximately €113M net of capital invested in the companies of the panel.
> Total amounts raised between January and April (€572.1M) increased by +164% compared to the same period in 2016 (€216.7M), with three times more funds raised via secondary issuance of shares And +21% via IPOs.

Euronext Corporate Services B.V. is incorporated under the laws of The Netherlands (Chamber of Commerce in Amsterdam under Registration no 68034970), having its registered office at Beursplein 5 (1012 JW) Amsterdam, The Netherlands. Euronext Corporate Services B.V. is part of the Euronext Group and a fully-owned subsidiary of Euronext N.V.